Cassiopea has taken control of a Phase II trial after the Israeli biotech it licensed the drug from shut down midstudy, delaying the data readout.

Former Acclarent CEO Bill Facteau has dealt with his fair share of legal drama after the Department of Justice (DOJ) accused him of improperly marketing one of…

Royal Philips will acquire Wellcentive per an agreement the former has announced. Wellcentive offers population health management software.

Startup Bigfoot Biomedical has started a clinical trial for its artificial pancreas device in Type 1 diabetes patients.

Fresh off a positive FDA panel earlier this month for what could be its first approved biosimilar for Humira, Amgen--and partner Allergan--have reported…

Beleaguered Theranos has hired a pair of industry executives in an apparent effort to right a ship that has been foundering in light of questions regarding the…

Brexit rejig leaves the U.K. without a life science minister, Shire takes a stake in Chronos, Poxel postpones its IPO and more.

Galderma Pharma has picked up the rights to a midphase atopic dermatitis and pruritus drug from Roche’s Chugai Pharmaceutical.